Danh mục

Efficacy and safety of maintenance immune checkpoint inhibitors with or without pemetrexed in advanced non-squamous non-small cell lung cancer: A retrospective study

Số trang: 9      Loại file: pdf      Dung lượng: 1.78 MB      Lượt xem: 17      Lượt tải: 0    
Hoai.2512

Xem trước 2 trang đầu tiên của tài liệu này:

Thông tin tài liệu:

Advanced non-squamous non-small cell lung cancer (NS-NSCLC) patients without driver gene mutations are usually treated with immune checkpoint inhibitors (ICIs) plus pemetrexed as maintenance therapy after first-line ICIs plus 4–6 cycles of pemetrexed/platinum. Some patients in the real world receive ICIs monotherapy as maintenance therapy.
Nội dung trích xuất từ tài liệu:
Efficacy and safety of maintenance immune checkpoint inhibitors with or without pemetrexed in advanced non-squamous non-small cell lung cancer: A retrospective study

Tài liệu được xem nhiều: